FA
FCG Advisors Portfolio holdings
AUM
$425M
This Quarter Return
-6.44%
1 Year Return
+12.08%
3 Year Return
+19.72%
5 Year Return
+52.92%
10 Year Return
–
AUM
$121M
AUM Growth
+$121M
(-4.8%)
Cap. Flow
+$14.8M
Cap. Flow
% of AUM
12.18%
Top 10 Holdings %
Top 10 Hldgs %
56.35%
Holding
85
New
6
Increased
53
Reduced
16
Closed
5
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$9.15M |
| 2 |
Vanguard Extended Market ETF
VXF
|
$1.12M |
| 3 |
iShares S&P 500 Growth ETF
IVW
|
$743K |
| 4 |
iShares MSCI EAFE ETF
EFA
|
$587K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
$358K |
Top Sells
| 1 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
$443K |
| 2 |
SPDR Bloomberg Barclays International Treasury Bond ETF
BWX
|
$272K |
| 3 |
Schlumberger
SLB
|
$252K |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
$228K |
| 5 |
Novartis
NVS
|
$211K |
Sector Composition
| 1 | Healthcare | 24.03% |
| 2 | Financials | 5.07% |
| 3 | Technology | 3.72% |
| 4 | Communication Services | 2.35% |
| 5 | Energy | 1.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intel
INTC
$105B
| $181K | 0.15% |
+10,660
| New | +$181K |
|
|
YTEN
77
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $115K | 0.09% |
12
+3
| +33% | +$28.8K |
|
|
TLRA
78
DELISTED
Telaria, Inc.
TLRA
| $46K | 0.04% |
+24,784
| New | +$46K |
|
|
ONCT
79
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $18K | 0.01% |
17
| – | – |
|
|
UQM
80
DELISTED
UQM Technologies, Inc.
UQM
| $6K | 0.01% |
10,000
| – | – |
|
|
RDS.A
81
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| – | – |
-4,003
| Closed | -$228K |
|
|
82
Schlumberger
SLB
$52.2B
| – | – |
-2,927
| Closed | -$252K |
|
|
83
Novartis
NVS
$248B
| – | – |
-2,390
| Closed | -$211K |
|
|
84
SPDR Bloomberg High Yield Bond ETF
JNK
$8.07B
| – | – |
-3,841
| Closed | -$443K |
|
|
85
SPDR Bloomberg Barclays International Treasury Bond ETF
BWX
$1.36B
| – | – |
-10,468
| Closed | -$272K |
|